clarithromycin has been researched along with clavulanic acid in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 9 (40.91) | 29.6817 |
| 2010's | 8 (36.36) | 24.3611 |
| 2020's | 1 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Burnham, LB; Citron, DM; Goldstein, EJ; Inderlied, CB; Kenner, MA | 1 |
| Aronoff, S; Arrieta, A; Aspin, MM; Hoberman, A; Lang, DJ; McCarty, J; McLinn, SE | 1 |
| McCarty, JM; Phillips, A; Wiisanen, R | 1 |
| Barry, B; Chauvin, JP; Géhanno, P; Hazebroucq, J | 1 |
| Cots, JM; Llor, C; Miravitlles, M; Molina, J; Naberan, K | 1 |
| Kardas, P; Muras, M | 1 |
| Lee, WK; Young, BW | 1 |
| Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
| Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K | 1 |
| Dehghani, SM; Erjaee, A; Haghighat, M; Imanieh, MH | 1 |
| Butler-Laporte, G; Menzies, D; Winters, N | 1 |
| Ahmed, MR; Mel-Hennawi, D | 1 |
| Chmielewska, M; Cieplak, M; Hadzik-Blaszczyk, M; Krupa, R; Kur, Z; Lenartowicz, B; Wardyn, KA; Zycinska, K | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Arenaz-Callao, MP; González Del Río, R; Lucía Quintana, A; Mendoza-Losana, A; Ramón-García, S; Thompson, CJ | 1 |
| Barth, SA; Häußler, TC; Köhler, K; Prenger-Berninghoff, E; Thom, N | 1 |
2 review(s) available for clarithromycin and clavulanic acid
| Article | Year |
|---|---|
Efficacy and safety of World Health Organization group 5 drugs for multidrug-resistant tuberculosis treatment.
Topics: Amoxicillin; Antitubercular Agents; Azithromycin; Cilastatin; Clarithromycin; Clavulanic Acid; HIV Infections; Humans; Imipenem; Isoxazoles; Macrolides; Meropenem; Mycobacterium tuberculosis; Oxazolidinones; Randomized Controlled Trials as Topic; Thienamycins; Thioridazine; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization | 2015 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
5 trial(s) available for clarithromycin and clavulanic acid
| Article | Year |
|---|---|
Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; beta-Lactamase Inhibitors; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Ear, Middle; Female; Humans; Infant; Male; Otitis Media; Single-Blind Method; Treatment Outcome | 1994 |
Comparative safety and efficacy of clarithromycin and amoxicillin/clavulanate in the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; beta-Lactamase Inhibitors; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Single-Blind Method; Treatment Outcome | 1993 |
[Clarithromycin versus amoxicillin-clavulanic acid in the treatment of acute maxillary sinusitis in adults].
Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Penicillins | 1996 |
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Single-Blind Method; Treatment Outcome; Urea | 2009 |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Case-Control Studies; Child; Child, Preschool; Chronic Disease; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors; Treatment Outcome | 2015 |
15 other study(ies) available for clarithromycin and clavulanic acid
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroidaceae; Child; Clarithromycin; Clavulanic Acid; Clavulanic Acids; Clostridium; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulbactam; Ticarcillin | 1995 |
Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Bronchitis, Chronic; Clarithromycin; Clavulanic Acid; Cost of Illness; Cost-Benefit Analysis; Data Collection; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Quinolines; Treatment Outcome | 2004 |
[A blinded comparison of palatability of 13 common pediatric antibiotic suspensions].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Clavulanic Acid; Clindamycin; Double-Blind Method; Female; Humans; Male; Patient Compliance; Pediatrics; Penicillins; Respiratory Tract Infections; Suspensions; Taste; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Community-Acquired Infections; Drug Prescriptions; Erythromycin; Hong Kong; Humans; Infant; Penicillin Resistance; Pneumonia, Pneumococcal; Practice Guidelines as Topic; Prevalence; Streptococcus pneumoniae | 2005 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2007 |
Antibiotic Treatment of Hospitalized Patients with Pneumonia Complicated by Clostridium Difficile Infection.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Clarithromycin; Clavulanic Acid; Clostridioides difficile; Clostridium Infections; Cross Infection; Female; Hospitalization; Host-Pathogen Interactions; Humans; Imipenem; Male; Pneumonia; Retrospective Studies; Treatment Outcome | 2016 |
Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening.
Topics: Administration, Oral; Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Buruli Ulcer; Clarithromycin; Clavulanic Acid; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycobacterium ulcerans; Rifampin | 2019 |
Challenging diagnosis and successful treatment of localised
Topics: Alkaline Phosphatase; Amoxicillin; Animals; Anti-Bacterial Agents; Clarithromycin; Clavulanic Acid; Dog Diseases; Dogs; Doxycycline; Female; Glossitis; Immunomodulation; Mycobacterium; Mycobacterium avium; Rifampin | 2022 |